Anyone using it should monitor IGF-1 and metabolic markers and work with a provider
Tirzepatide produces more total weight loss, but a meaningful percentage of that loss comes from lean mass, which is why the peptides for muscle growth category has become increasingly relevant to people on aggressive weight loss protocols
Phase 2 trial (NEJM, 2023) The landmark Phase 2 trial, published in the New England Journal of Medicine, randomized 338 adults with obesity to receive weekly subcutaneous retatrutide at doses of 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, for 48 weeks
And sometimes, whats a risk or benefit for one person isnt for another
The menisci that provide knee stability and shock absorption can degenerate, extrude, develop tears, or completely wear away